In NSCLC, TNFR2+ Tregs presented in the peripheral blood and pleural effusion of NSCLC patients were more proliferative and expressed a higher degree of CTLA-4 molecules to mediate immunosuppression than TNFR2- Tregs [53, 54]. Here, TNFRSF1B is linked to Pleural effusion.